We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Companies can find it challenging to figure out the most efficient and compliant method to bring new medical devices to the U.S. market. A thorough understanding of the nuances involved in FDA regulation of new devices is necessary for companies to successfully launch new products in the U.S. without regulatory complications. Both regulatory and business factors must be considered.
Penn Medicine cancer center in Philadelphia has performed the first ever patient treatment with Varian’s Halcyon and Ethos radiotherapy systems using the company’s HyperSight imaging technology.
The European Medicines Agency (EMA) is taking on a new role in monitoring and mitigating medical device shortages during public health emergencies, through a yet-to-be-created Medical Devices Shortages Steering Group (MDSSG).
Device developers and other stakeholders are encouraged to include both on-site and virtual site proposals and to address patient engagement as a supplemental topic.